本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 南京高科股份有限公司（以下简称"公司"）于 2023 年 5 月 25 日召开公司 2022 年年度股东大会，审议通过了《关于公司发行短期 融资券的议案》，同意公司向中国银行间市场交易商协会申请注册发 行不超过人民币 20 亿元（含 20 亿元）的短期融资券。2024 年 1 月 31 日，中国银行间市场交易商协会接受公司短期融资券注册。根据 中市协注[2024]CP26 号《接受注册通知书》，公司短期融资券注册金 额为 19 亿元，注册额度自通知书落款之日（2024 年 2 月 7 日）起 2 年内有效，公司在注册有效期内可分期发行短期融资券。 证券简称：南京高科 证券代码：600064 编号：临 2024-035 号 南京高科股份有限公司 2024 年度第二期短期融资券发行结果公告 本次短期融资券发行的有关文件详见中国货币网（www.chinamo ney.com.cn）和上海清算所网站（www.shclearing.com.cn）。 特此公告。 南京高科股份有限公司 ...

证券简称：南京高科 证券代码：600064 编号：临 2024-034 号 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 根据《上海证券交易所上市公司自律监管指引第 3 号——行业信 息披露》要求，特此公告南京高科股份有限公司（以下简称"公司"） 2024 年第 3 季度房地产业务相关经营数据。 2024 年 1-9 月，公司无新增房地产项目储备。 2024 年 7-9 月，公司房地产业务无新开工，无新竣工。2024 年 1-9 月，公司房地产业务新开工面积 5.16 万平方米，权益新开工面积 3.72 万平方米；竣工面积 6.17 万平方米，权益竣工面积 4.93 万平方 米。 2024 年 7-9 月，公司房地产业务实现合同销售面积 0.18 万平方 米（均为商品房项目销售），同比减少 47.06%，实现权益合同销售面 积 0.12 万平方米（均为商品房项目销售），同比减少 61.29%；实现合 同销售金额 7,488.68 万元（均为商品住宅、车位等项目销售），同比 减少 36.81%，实现权益合同销售金额 5, ...

Investment Rating - The investment rating for the company is "Outperform the Market" and is maintained [1] Core Views - The company reported a significant decline in revenue and net profit for the first half of 2024, with operating income of 1.044 billion yuan, down 62.35% year-on-year, and net profit attributable to the parent company of 1.023 billion yuan, down 11.69% year-on-year [5] - The municipal revenue showed growth, with municipal business revenue reaching 598 million yuan, an increase of 30.23% year-on-year, while the real estate business faced substantial declines in both sales area and revenue [5] - The company is focusing on technological innovation and market expansion in sectors such as biomedicine and semiconductor materials, and has become the largest shareholder of Chenpai Pharmaceutical [5][6] - The company has a low debt level, with a debt-to-asset ratio of 49.16% and an average financing cost of 2.81%, which is a decrease of 0.27 percentage points year-on-year [6] - The reasonable value range for the company's stock is estimated to be between 6.00 and 7.00 yuan, with projected EPS for 2024 and 2025 at 1.00 yuan and 1.11 yuan respectively [6] Summary by Sections Financial Performance - In the first half of 2024, the real estate business saw a contract sales area of 0.27 million square meters, a decrease of 98.92%, and a contract sales amount of 123 million yuan, down 92.91% year-on-year [5] - The company achieved an investment income of 1.057 billion yuan, a decrease of 7.32% year-on-year, and a fair value change loss of 112 million yuan [5] Future Outlook - The company plans to continue analyzing market and industry trends to enhance competitiveness and promote stable business development [6] - The company aims to innovate sales strategies and actively explore policies to boost sales and cash flow in the real estate sector [6] Valuation Metrics - The projected financial metrics for the company include operating income of 5.073 billion yuan for 2024, with a year-on-year growth of 7.2%, and net profit of 1.728 billion yuan, reflecting a year-on-year growth of 10.8% [8] - The company’s average financing cost is expected to remain low, supporting its operational efficiency [6]

Investment Rating - The report maintains a "Buy" rating for Nanjing Gaoke (600064 SH) [1][3] Core Views - Revenue and net profit declined in H1 2024, with revenue down 62 35% YoY to 1 044 billion yuan and net profit down 11 69% YoY to 1 023 billion yuan [3] - Gross margin improved by 5 75 percentage points to 16 92%, while net margin surged by 56 55 percentage points to 98 64% due to a significant increase in investment income relative to revenue [3] - The company's diversified business and smooth financing channels are expected to drive continuous performance improvement [3] Business Performance - Real estate development revenue dropped 80 73% YoY to 446 million yuan, while municipal infrastructure construction revenue grew 46 07% YoY to 430 million yuan [4] - Investment income decreased by 7 32% YoY to 1 057 billion yuan, with a fair value change loss of 112 million yuan [4] - The company held securities with a book value of 2 494 billion yuan as of June 30, 2024 [4] Financial Performance - Operating cash flow was negative at 592 million yuan in H1 2024, indicating room for improvement [5] - The company's asset liability ratio stood at 49 16%, with a current ratio of 1 18 and a quick ratio of 0 42 [5] - Period expenses increased by 2 percentage points to 2 98% [5] Financing and Liquidity - The company issued two tranches of ultra short term bonds totaling 1 25 billion yuan in H1 2024, with coupon rates of 2 73% and 2 35%, maintaining low financing costs [6] - As of June 30, 2024, the company had a loan balance of 500 million yuan with Nanjing Bank, with total interest payments of 7 1778 million yuan in H1 2024 [6] Valuation and Forecast - The report forecasts net profit of 1 91 billion yuan, 2 21 billion yuan, and 2 46 billion yuan for 2024 2026, with EPS of 1 1 yuan, 1 3 yuan, and 1 4 yuan respectively [3] - The current stock price implies a PE ratio of 5 2x, 4 5x, and 4 1x for 2024 2026 [3]

重要内容提示： 欢迎投资者于 2024 年 9 月 11 日前将关注的问题通过电子邮件的形式发 送至本公司邮箱：600064@600064.com。公司将通过业绩说明会在信息披露允许 的范围内对投资者普遍关注的问题进行解答。 一、说明会类型 公司已于 2024 年 8 月 30 日在《中国证券报》《上海证券报》《证 券时报》及上海证券交易所网站（www.sse.com.cn）上披露了 2024 年半年度报告及摘要。为让广大投资者更全面深入的了解公司经营业 绩等具体情况，公司决定以网络互动方式举行"2024 年半年度业绩 说明会"。 证券简称：南京高科 证券代码：600064 编号：临 2024-033 号 南京高科股份有限公司 2024 年半年度网上业绩说明会预告公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 二、说明会召开时间和形式 召开时间：2024 年 9 月 12 日（周四）15:00-16:00 召开形式：网络文字互动 三、公司出席说明会的人员 公司董事长、党委书记徐益民先生，董事、总裁陆阳俊先生，独 1 ...

Financial Performance - The company's operating revenue for the first half of 2024 was ¥1,043,771,342.20, a decrease of 62.35% compared to ¥2,772,013,406.43 in the same period last year[13]. - The net profit attributable to shareholders of the listed company was ¥1,022,701,962.75, down 11.69% from ¥1,158,031,412.41 in the previous year[13]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥1,103,698,659.67, a decrease of 11.37% compared to ¥1,245,299,422.46 in the same period last year[13]. - Basic earnings per share decreased by 11.66% to CNY 0.591 compared to CNY 0.669 in the same period last year[14]. - Weighted average return on equity decreased by 1.11 percentage points to 5.67% from 6.78% year-on-year[14]. - The company's operating revenue decreased primarily due to reduced income from affordable housing project sales[14]. - The real estate business recorded a contract sales area of 0.27 million square meters, a decline of 98.92% year-on-year[22]. - The municipal business generated operating revenue of CNY 59,813.03 million, an increase of 30.23% year-on-year[22]. - The company reported a net profit of ¥4,998.61 million from its subsidiary Nanjing Gaoke Real Estate Co., Ltd., with total assets of ¥1,310,726.41 million[41]. - The company reported a net profit for the first half of 2024 of CNY 1,029,581,235.85, down 11.7% from CNY 1,166,641,643.08 in the first half of 2023[79]. Cash Flow and Financial Position - The net cash flow from operating activities was -¥591,556,107.67, compared to -¥295,040,680.43 in the previous year[13]. - The net cash flow from investment activities was CNY 696,697,712.73, an increase of 22.57% from CNY 568,420,719.47[27]. - The net cash flow from financing activities decreased by 96.52% to CNY 26,415,124.06, down from CNY 759,067,016.83[27]. - The company's asset-liability ratio stood at 49.16%, with total interest-bearing liabilities of CNY 10.234 billion, accounting for 26.56% of total assets[23]. - The company's cash flow from operating activities decreased due to a reduction in the sales amount of commercial housing contracts[27]. - The total cash and cash equivalents at the end of the first half of 2024 were 436,396,751.96 RMB, down from 666,380,619.01 RMB at the end of the first half of 2023[84]. - The total liabilities at the end of the reporting period amounted to CNY 19,592,444,724.36, indicating the company's financial obligations[88]. Investment and Strategic Focus - The company is focusing on technology innovation sectors such as healthcare and semiconductor materials for equity investments[19]. - The company plans to gradually exit the real estate development business over the next 3-5 years, focusing on high-tech industry investments[25]. - The company aims to enhance resource integration and risk management capabilities through its two platforms, focusing on collaborative development[19]. - The company has filed for 13 invention and utility model patents during the reporting period, reflecting its commitment to technological innovation[22]. - The company is actively pursuing new investment projects while managing existing risks associated with market competition and liquidity[44]. Risk Management and Compliance - The company has detailed descriptions of potential risks including macroeconomic risks, business development risks, investment management risks, and financial risks in the report[4]. - The report has not been audited, and the board of directors and management have confirmed the accuracy and completeness of the financial report[3]. - The company plans to enhance risk management strategies to address potential financial pressures from real estate and investment sectors[44]. - The company has successfully revised its emergency response plan for environmental incidents, ensuring preparedness for potential pollution events[51]. - The company has not faced any administrative penalties related to environmental issues during the reporting period[53]. Shareholder and Corporate Governance - The company has not proposed any profit distribution plan or capital reserve transfer to share capital for this reporting period[2]. - The total number of ordinary shareholders as of the report date is 45,650, reflecting a stable shareholder base[64]. - The largest shareholder, Nanjing New Port Development Co., Ltd., holds 601,083,220 shares, accounting for 34.74% of the total shares[65]. - The company completed the re-election of the 11th Board of Directors and Supervisory Board in August 2024, appointing new senior management personnel[46]. - The company has not reported any changes in its share capital structure during the reporting period[63]. Environmental and Social Responsibility - The company has actively participated in social responsibility initiatives, including charity events and volunteer services, contributing to regional development[55]. - The company has implemented energy-saving measures in project development, utilizing low-carbon building materials to reduce carbon emissions[54]. - The company has maintained stable effluent quality that meets Class A standards, contributing to ecological maintenance while pursuing technological innovation[54]. Accounting and Financial Reporting - The company's financial statements are prepared in accordance with the accounting standards issued by the Ministry of Finance, ensuring a true and complete reflection of its financial status as of June 30, 2024[96]. - The company recognizes revenue from real estate development when all conditions are met, including signing contracts and obtaining payment proof[159]. - The company uses the output method to recognize revenue in construction contracts based on the proportion of actual completed work to estimated total work[160]. - The company recognizes sales revenue for pharmaceuticals when goods are dispatched, and the customer has received the goods or payment rights[163]. - The company assesses expected liabilities based on the best estimate of required expenditures, considering risks and uncertainties[158].

证券代码：600064 证券简称：南京高科 公告编号：临 2024-030 号 南京高科股份有限公司 2024 年第一次临时股东大会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： (二) 股东大会召开的地点：公司会议室 (三) 出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： 本次会议是否有否决议案：无 一、 会议召开和出席情况 (一)股东大会召开的时间：2024 年 8 月 12 日 | 1、出席会议的股东和代理人人数 | 268 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 677,537,933 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | 39.1563 | | 份总数的比例（%） | | (四) 表决方式是否符合《公司法》及《公司章程》的规定，大会主持情况等。 本次会议以现场和网络投票相结合的方式召开，会议的表决方式符合《公司 法》及《公司章程》的规定，现场会议由公司董事长徐益民先生主持。 1 (五) 公司董事、监事 ...

证券简称：南京高科 证券代码：600064 编号：临 2024-032 号 南京高科股份有限公司 监 事 会 二○二四年八月十三日 1 南京高科股份有限公司 第十一届监事会第一次会议决议公告 本公司监事会及全体监事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 南京高科股份有限公司第十一届监事会第一次会议于 2024 年 8 月 12 日以现场结合通讯表决的方式召开，会议通知于 2024 年 7 月 29 日以邮件和电话的方式发出。本次会议应参加表决的监事 3 名， 实际参加表决的监事 3 名，符合《公司法》和《公司章程》的有关规 定。本次会议审议并通过了《关于选举公司监事会主席的议案》，选 举吕晨先生为公司监事会主席，任期三年。 表决结果：同意 3 票，反对 0 票，弃权 0 票。 特此公告。 附件：监事会主席吕晨先生简历 附件： 监事会主席吕晨先生简历 吕晨，男，1970 年 1 月生，汉族，江苏泰州人，大学学历，高 级工程师。曾任南京港口建设指挥部技术员，本公司助理工程师，南 京新港工程设计所副所长，南京高科工程设计研究院有限公司经理， ...

江苏金鼎英杰律师事务所 法律意见书 江苏金鼎英杰律师事务所关于 南京高科股份有限公司 2024年第一次临时股东会之 法律意见书 中国江苏省南京市汉中门大街309号 B座7层（210036） 7F,BlockB,309HanzhongmenDajie,Nanjing, China,210036 电话/Tel:+86-25-89660961 2024年8月12日 江苏金鼎英杰律师事务所 关于南京高科股份有限公司 2024年第一次临时股东会之 法律意见书 致：南京高科股份有限公司 根据《中华人民共和国公司法》（以下简称"《公司法》"）《中华 人民共和国证券法》（以下简称"《证券法》"）和中国证券监督管理委 员会《上市公司股东大会规则》（以下简称"《股东大会规则》"）及 《上海证券交易所上市公司自律监管指引第1号——规范运作》（以下简 称"《自律监管指引第1号》"）的规定，江苏金鼎英杰律师事务所（以下 简称"本所"）接受南京高科股份有限公司（以下简称"公司"）的委托， 指派戴克勤律师、张宁律师出席并见证了公司于2024年8月12日在南京高 科股份有限公司会议室召开的公司2024年第一次临时股东会，并依据有 关法律、法 ...

证券简称：南京高科 证券代码：600064 编号：临 2024-031 号 南京高科股份有限公司 第十一届董事会第一次会议决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 南京高科股份有限公司第十一届董事会第一次会议于 2024 年 8 月 12 日下午 4:00 在公司会议室召开。会议通知于 2024 年 7 月 29 日 以邮件和电话的方式发出。本次会议应到董事 7 名，实到 7 名，公司 监事及高级管理人员列席了会议，符合《公司法》和《公司章程》的 有关规定。本次会议审议并通过了以下议案： 一、关于选举公司董事长的议案； 选举徐益民先生为公司董事长，任期三年。 表决结果：同意 7 票，反对 0 票，弃权 0 票，表决通过。 二、关于公司董事会专门委员会组成人员的议案； 四、关于聘任公司副总裁的议案； 经总裁提名，同意聘任谢建晖女士为公司副总裁，任期三年。 表决结果：同意 7 票；反对 0 票；弃权 0 票，表决通过。 经总裁提名，同意聘任周克金先生为公司副总裁，任期三年。 表决结果：同意 7 票；反对 0 ...